Vera Therapeutics Vera logo

SEC Filings

Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

View HTML

Data provided by Kaleidoscope.

Top